NewsRoom Articles - Page 100 of 112

WednesdayApr 11, 2018 1:47 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Provides Update on Bio-Cannabis Product Pipeline

Several proprietary products developed and ready to market in Canada, California and global markets Cannabis product sales expected to generate significant revenue Pivot’s IP portfolio includes global patents to cement its leading position in the cannabis industry On April 4, 2018, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) published an update on the advancements of its industry-leading cannabis product pipeline (http://cnw.fm/37EFo). A newly developed 1% cannabidiol (CBD) oral micelle solution, created in collaboration with the company’s German technology partner, Solmic GmbH, is ready to market. The development of two topical creams using Pivot’s patented formulation and delivery systems…

WednesdayApr 11, 2018 11:11 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Tech Promises Versatile Commercial Applications

DehydraTECH™ has been shown to improve the taste, smell, bioabsorption and bioavailability of high performance ingestible consumer products Lexaria is working to eliminate negative side effects and enhance the healthy benefits of a variety of bioactive compounds Research being conducted for healthier oral ingestion of vitamins, nicotine and opioids DehydraTECH™ is a unique enabling technology from Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) that increases the absorption rate of edible ingestion, delivering five to 10 times more of active ingredients than traditional edibles. This technology is not a competing technology but rather a complementary layer that provides a versatile range…

TuesdayApr 10, 2018 10:43 am

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) Growing Patent Portfolio Enables Commercialization, Defense of DehydraTECH

LXRP recently received a new U.S. patent allowance for ‘composition of matter’ related to its DehydraTECH™ platform’s delivery of cannabinoids; based on past experience, company expects formal granting of patent within 100 days Company filed new U.S. patent application for use of DehydraTECH to improve the speed of absorption of active pharmaceutical ingredients through the skin; compared to other commercial formulations, LXRP product exhibited up to a 225 percent increase in permeability LXRP gets primary revenue through third party licensing fees related to its proprietary and patented intellectual property; goal is to partner with leading firms globally to deliver best-in-class…

FridayApr 06, 2018 2:00 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Extracts Maximum Benefit from Cannabis Portfolio

Forecasts predict $55.8 billion valuation for medical cannabis market by 2025 Pivot Pharmaceuticals building portfolio of diverse tech for improving bioavailability of cannabinoid therapies Company’s leadership team builds on decades of experience in pharmaceutical arena For nutrition-conscious consumers, scanning food product labels is a requisite part of any trip to the grocery store, but a recent study by the U.S. Department of Agriculture’s Agricultural Research Service (http://cnw.fm/i21Ex) found that the old maxim ‘what you see isn’t always what you get’ holds true when it comes to certain foods like nuts. Even though pistachios, for example, may have 161.9 calories per ounce,…

WednesdayApr 04, 2018 1:38 pm

Xanthic Biopharma Inc. Establishing a New Paradigm in Cannabinoid Delivery

Filed patents to protect company’s process and products Powderized cannabis products deliver precise CBD/THC dosing with superior cannabinoid solubility Signed strategic partnership and licensing agreement with Avitas CBD Water After thousands of years of human use, cannabis is now at the center of a new revolution. The medical efficacy of certain cannabinoids is now settled science, and numerous advanced therapeutic applications are currently in development. Recreational cannabis use has gained broad acceptance in multiple U.S. states and, in a few months, becomes legal across all of Canada. However, whether for medicinal or recreational purposes, there have been long-standing problems with…

TuesdayApr 03, 2018 9:00 am

Infusion of Biotechnology Into Cannabis Market Leads to Booming Growth

CanadianCannabisWire Editorial Coverage: The tremendous growth of the licensed cannabis market has naturally led to an increase in research in this area. A number of specialist biotech companies have emerged, creating innovative cannabinoid applications. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has developed technology to improve the palatability and speed of absorption of cannabinoid therapeutics, leading to a range of licensed products and related patents. Plant biotechnology company 22nd Century Group, Inc. (NYSE American: XXII) is altering the level of active ingredients in both cannabis and tobacco, allowing new strains to be grown for medical and other purposes.…

ThursdayMar 29, 2018 9:00 am

Cannabis Continues to Provide Progress in Medical Sector

CanadianCannabisWire Editorial Coverage: The emergence of a legal recreational cannabis sector has drawn attention away from the medical cannabis market. However, many companies continue to move forward in this strong sector, benefiting from extensive research and development work. PreveCeutical Medical, Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is developing new cannabis-based medicines and delivery systems through partnership with researchers in Australia. Invictus MD Strategies Corporation (TSX-V: GENE) (OTC: IVITF) has created a network of profitable growing facilities that allowed the company to pay out a million-dollar dividend in 2016, the first dividend payout by a Canadian cannabis company, and Radient…

WednesdayMar 28, 2018 12:49 pm

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Building Seasoned Leadership Team for Growing Cannabis Portfolio

Cannabis investments have already exceeded $2 billion in 2018 Liberty Leaf bolstering scientific, legal and accounting strength with experienced leadership additions Development projects include in-house, GMP-compliant manufacturing Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is accelerating the potential of companies supplying the cannabis industry as it builds its vision of a ‘trellis of commerce’ that connects players in the legal markets for marijuana and related consumables. During the past year, the Canadian company has fostered research and development into the potential of using pet-friendly cannabidiol (CBD) for the treatment of beloved animals that suffer from arthritic pain,…

TuesdayMar 27, 2018 1:40 pm

The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX: TNYBF) Brings Healthy Hemp and Cannabis Drinks to Market

Soft drink and alcohol sales plummet as Americans guzzle healthier drinksMillennials are switching to functional drinks and cannabisTinley meets market needs with wholesome hemp and cannabis beveragesSoda is losing its pop. Hit with new taxes on sugar and repelled by fears of putting on weight, Americans are consuming fewer soft drinks. A 1.2 percent decrease in 2016 marked the 12th consecutive annual decline in sales of soda drinks in the U.S. This trend will undoubtedly continue as more localities impose sugar taxes, meant to discourage the consumption of sweetened beverages and mitigate the costs of treating the overweight. Added sugar…

TuesdayMar 27, 2018 11:35 am

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Named to the CSE25 Index

Pivot Pharmaceuticals attains prestigious CSE25 status Recent acquisitions have extended the company’s portfolio in the cannabis space Numerous pharmaceutical and nutraceutical products in development pipeline Canadian biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) announced on March 19, 2018, that it has been named to the CSE25 Index (http://cnw.fm/g1qK7). CSE25 is a conglomerate of the 25 largest companies by market capitalization listed on the Canadian Securities Exchange. This achievement adds to Pivot Pharmaceuticals’ status as a constituent of the CSE Composite Index, which provides a distinctly different risk/return profile than the broad Canadian equity market. "With an…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977